RYOAX Mutual Fund

RYOAX Mutual Fund

NAV$74.75
See how much of RYOAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$6M
Expense Ratio
1.63%
Dividend Yield (Current)
-
Holdings
72
Inception Date
Apr 1, 1998
Fund Family
Rydex Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+31.06%
1 Year+39.26%
3 Year+26.77%
5 Year+8.56%
10 Year+11.32%

Asset Allocation

Stocks: 99.39%
Other: 0.61%
See how much of RYOAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
ABBVAbbvie Inc.7.88%
AMGNAmgen Inc.5.67%
GILDGilead Sciences4.93%
VRTXVertex Pharmaceuticals Inc4.48%
MRNAModerna Inc4.08%
Top 10 Concentration: 40.38%Report Date: Aug 31, 2026
Download all 72 holdings for RYOAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$15.77
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

RYOAX Mutual Fund Overview

RYOAX Mutual Fund (Rydex Biotechnology Fund Class H) is managed by Rydex Funds with $5.8M in net assets. RYOAX expense ratio is 1.63%, holding 72 positions across sectors including Health Care. Inception date: 1998-04-01.

RYOAX performance shows a YTD return of 31.06%. The 1-year return is 39.26% and the 5-year return is 8.56%.

RYOAX top holdings include Abbvie Inc. (7.9%), Amgen Inc. (5.7%), Gilead Sciences (4.9%), Vertex Pharmaceuticals Inc (4.5%), Moderna Inc (4.1%). Go to all RYOAX holdings, RYOAX sectors, or RYOAX dividends.

RYOAX can be compared against other funds. Use RYOAX overlap to find shared positions, or RYOAX vs another fund for a side-by-side view. RYOAX alternatives are available via the screener, along with tax-loss harvesting opportunities.